NO20064814L - Fremgangsmate for forebygging av nodavirusinfeksjon og terapeutisk fremgangsmate - Google Patents

Fremgangsmate for forebygging av nodavirusinfeksjon og terapeutisk fremgangsmate

Info

Publication number
NO20064814L
NO20064814L NO20064814A NO20064814A NO20064814L NO 20064814 L NO20064814 L NO 20064814L NO 20064814 A NO20064814 A NO 20064814A NO 20064814 A NO20064814 A NO 20064814A NO 20064814 L NO20064814 L NO 20064814L
Authority
NO
Norway
Prior art keywords
fish
nodavirus
infection
prevention
therapeutic method
Prior art date
Application number
NO20064814A
Other languages
English (en)
Inventor
Toshihiro Nakai
Original Assignee
Japan Science & Tech Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency filed Critical Japan Science & Tech Agency
Publication of NO20064814L publication Critical patent/NO20064814L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/30011—Nodaviridae
    • C12N2770/30034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

En preventiv eller terapeutisk fremgangsmåte for infeksjon av fisk med nodavirus eller sykdommer, slik som virusnervenekrose, som skyldes nodavirusinfeksjon. Forebygging av infeksjon av fisk med nodavirus, eller forebygging eller behandling av sykdom, slik som virusnervenekrose som er utviklet på grunn av nodavirusinfeksjon, kan oppnås ved å utføre perkutan inokulering av fisk med aquabimavirus i injeksjon eller å dyppe fisken i en væske inneholdende aquabimavirus, eller ved å gi et fér som har iblandet aquabimavirus, til fisken.
NO20064814A 2004-03-24 2006-10-23 Fremgangsmate for forebygging av nodavirusinfeksjon og terapeutisk fremgangsmate NO20064814L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004086929A JP2005272340A (ja) 2004-03-24 2004-03-24 ノダウイルスの感染予防法および治療法
PCT/JP2005/005265 WO2005089781A1 (ja) 2004-03-24 2005-03-23 ノダウイルスの感染予防法および治療法

Publications (1)

Publication Number Publication Date
NO20064814L true NO20064814L (no) 2006-10-23

Family

ID=34993439

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064814A NO20064814L (no) 2004-03-24 2006-10-23 Fremgangsmate for forebygging av nodavirusinfeksjon og terapeutisk fremgangsmate

Country Status (10)

Country Link
US (1) US20070218036A1 (no)
EP (1) EP1731159A1 (no)
JP (1) JP2005272340A (no)
KR (1) KR20060131931A (no)
CN (1) CN1960740A (no)
AU (1) AU2005224913A1 (no)
CA (1) CA2560300A1 (no)
NO (1) NO20064814L (no)
TW (1) TW200534865A (no)
WO (1) WO2005089781A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101016547B (zh) * 2007-01-25 2010-07-28 浙江大学 海洋双rna病毒mabv重组蛋白的制备方法与应用
CN103229737B (zh) * 2013-04-26 2015-08-05 宁波大学 网箱养殖大黄鱼细菌性疾病大规模发生时间的预报

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171591B1 (en) * 1997-12-08 2001-01-09 Pentamer Pharmaceuticals, Inc. Recombinant nodavirus compositions and methods
JPH11322791A (ja) * 1998-05-11 1999-11-24 Fisheries Agency 魚類ノダウイルスの組換外被タンパク質
JP2001278896A (ja) * 2000-03-27 2001-10-10 Fisheries Agency ハタ類のウイルス性神経壊死症原因ウイルスの組換え外被タンパク質

Also Published As

Publication number Publication date
KR20060131931A (ko) 2006-12-20
WO2005089781A1 (ja) 2005-09-29
JP2005272340A (ja) 2005-10-06
CA2560300A1 (en) 2005-09-29
EP1731159A1 (en) 2006-12-13
CN1960740A (zh) 2007-05-09
AU2005224913A1 (en) 2005-09-29
TW200534865A (en) 2005-11-01
US20070218036A1 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
WO2019193183A3 (en) Novel yellow fever nucleic acid molecules for vaccination
NO20064572L (no) Tradisjonelt kinesisk medisinsk preparat for kardio-cerebrale blodkarsykdommer, og fremgangsmater for fremstilling av samme
EA201101187A1 (ru) Антидиабетические лекарственные средства, содержащие ингибитор dpp-4 (линаглиптин) необязательно в комбинации с другими антидиабетическими средствами
DK1885382T3 (da) Fremgangsmåder til anvendelse af adipøst vævs-afledte celler i behandlingen af cardiovaskulære tilstande
BRPI0814737A2 (pt) Composição, métodos para reduzir, retardar ou de um outro modo inibir o crescimento e/ou replicação de hcv, para prevenir a infecção de uma célula exposta a hcv, para tratar terapeuticamente ou profilaticamente um paciente exposto ou infectado com hcv, e para tratar hepatite c, e, uso de uma composição.
NO20081838L (no) 5-lipoksygenaseaktiverende protein-(FLAP)-inhibitorer
MY202109A (en) Viral replication inhibitors
DE602005018181D1 (de) Materialien und methoden zur behandlung von koagulationsstörungen
EA201100390A1 (ru) Соединения для лечения гепатита с
DK1599575T3 (da) Fremgangsmåder til anvendelse af adipøst vævs-afledte celler i behandlingen af kardiovaskulære tilstande
BRPI0908489A2 (pt) uso de compostos químicos e método para desenhar compostos químicos que atenuam ou inibem a infecção pelo vírus da dengue
WO2010029089A3 (en) Combination therapy for the treatment of diabetes and related conditions
EA201000515A1 (ru) Активаторы глюкокиназы
NO20083036L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon
WO2006073890A3 (en) Use of glp-1 and agonists thereof to prevent cardiac myocyte apoptosis
EA200501710A1 (ru) Замещённые карбоновые кислоты
DK1778680T3 (da) Spirocykliske cyclohexaderivater
EA200870088A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов и глюкозы в крови
MX2007005523A (es) Metodo para el tratamiento preventivo de alergias mediante administracion en mucosas de una vacuna contra alergias.
ATE525084T1 (de) Verwendung von mindestens einem botulinum- neurotoxin zur behandlung von schmerzen infolge therapeutischer behandlungen für das aids-virus
IL203982B (en) Devices for generating air with allicin
EA201691420A1 (ru) Композиции енолазы 1 (eno1) и их применение
EA201790563A1 (ru) Применение реслизумаба для лечения эозинофильной астмы со степенью тяжести от умеренной до тяжелой
WO2008157787A3 (en) Hydroxylated tolans and related compounds in the treatment of cancer
Nguyen Containing the spread of COVID-19 virus facing to its high mutation rate: approach to intervention using a nonspecific way of blocking its entry into the cells

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application